![THERAPY OF ENDOCRINE DISEASE: Denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosis in: European Journal of Endocrinology Volume 179 Issue 1 (2018) THERAPY OF ENDOCRINE DISEASE: Denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosis in: European Journal of Endocrinology Volume 179 Issue 1 (2018)](https://eje.bioscientifica.com/view/journals/eje/179/1/images/EJE-18-0056fig1.jpeg)
THERAPY OF ENDOCRINE DISEASE: Denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosis in: European Journal of Endocrinology Volume 179 Issue 1 (2018)
![Medicina | Free Full-Text | Immunohistochemical Femoral Nerve Study Following Bisphosphonates Administration | HTML Medicina | Free Full-Text | Immunohistochemical Femoral Nerve Study Following Bisphosphonates Administration | HTML](https://www.mdpi.com/medicina/medicina-56-00140/article_deploy/html/images/medicina-56-00140-g003.png)
Medicina | Free Full-Text | Immunohistochemical Femoral Nerve Study Following Bisphosphonates Administration | HTML
![Cellular and molecular mechanisms of action of bisphosphonates - Rogers - 2000 - Cancer - Wiley Online Library Cellular and molecular mechanisms of action of bisphosphonates - Rogers - 2000 - Cancer - Wiley Online Library](https://acsjournals.onlinelibrary.wiley.com/cms/attachment/b81bb956-7d51-421a-8ecd-41e45cc1c166/mfig005.jpg)
Cellular and molecular mechanisms of action of bisphosphonates - Rogers - 2000 - Cancer - Wiley Online Library
![Bisphosphonates in Chronic Kidney Disease; Balancing Potential Benefits and Adverse Effects on Bone and Soft Tissue | American Society of Nephrology Bisphosphonates in Chronic Kidney Disease; Balancing Potential Benefits and Adverse Effects on Bone and Soft Tissue | American Society of Nephrology](https://cjasn.asnjournals.org/content/clinjasn/4/1/221/F1.large.jpg)
Bisphosphonates in Chronic Kidney Disease; Balancing Potential Benefits and Adverse Effects on Bone and Soft Tissue | American Society of Nephrology
![Anabolic and antiresorptive actions of locally delivered bisphosphonates for bone repair | Bone & Joint Research Anabolic and antiresorptive actions of locally delivered bisphosphonates for bone repair | Bone & Joint Research](https://online.boneandjoint.org.uk/cms/10.1302/2046-3758.710.BJR-2018-0015.R2/asset/images/medium/2046-3758.710.bjr-2018-0015.r2-fig1.gif)
Anabolic and antiresorptive actions of locally delivered bisphosphonates for bone repair | Bone & Joint Research
![Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy | SpringerLink Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00198-007-0540-8/MediaObjects/198_2007_540_Fig8_HTML.gif)
Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy | SpringerLink
![Denosumab: mechanism of action and clinical outcomes - Hanley - 2012 - International Journal of Clinical Practice - Wiley Online Library Denosumab: mechanism of action and clinical outcomes - Hanley - 2012 - International Journal of Clinical Practice - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/1f5b0bc0-32e9-4e7e-a668-784d55e0870f/ijcp_12022_f2.gif)
Denosumab: mechanism of action and clinical outcomes - Hanley - 2012 - International Journal of Clinical Practice - Wiley Online Library
![Prevention of vascular calcification with bisphosphonates without affecting bone mineralization: a new challenge? - Kidney International Prevention of vascular calcification with bisphosphonates without affecting bone mineralization: a new challenge? - Kidney International](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2043430681/2056027240/gr1.jpg)
Prevention of vascular calcification with bisphosphonates without affecting bone mineralization: a new challenge? - Kidney International
![Figure 2 from Denosumab and bisphosphonates: different mechanisms of action and effects. | Semantic Scholar Figure 2 from Denosumab and bisphosphonates: different mechanisms of action and effects. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d6bfb56981da65d6ca7c425d90adbe172e1d2c58/4-Figure2-1.png)
Figure 2 from Denosumab and bisphosphonates: different mechanisms of action and effects. | Semantic Scholar
![Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy | SpringerLink Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00198-007-0540-8/MediaObjects/198_2007_540_Fig6_HTML.gif)
Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy | SpringerLink
![Possible ocular adverse effects attributable to bisphosphonate therapy: Two case reports | Revista Colombiana de Reumatología (English Edition) Possible ocular adverse effects attributable to bisphosphonate therapy: Two case reports | Revista Colombiana de Reumatología (English Edition)](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S2444440517300274:gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w997EogCnBdOOD93cPFbanNc1SMvz46gXX2zWoVNOOjrSTwdN3jKSy8lwLSDyjyDlrMClK15O8Mmd01j+kn7NA+NH9QXa7K4ey/Rqh70O9B39o57t3RZQc8r9gps9ZliwnuhnTo5ExeaYRj/HhH6d2RQWo4BGGqYbmDD/ULNpaxlTWqg4fhuw18QNPpM+9YkwSzy635OyeKndIRgjR7e4mGZVYfszHglOCKmKkfTpt6QgAVIbKYJAIrKEfVP3qDu/JEjWtY0pYaX+/iLeXcsq+oY=)
Possible ocular adverse effects attributable to bisphosphonate therapy: Two case reports | Revista Colombiana de Reumatología (English Edition)
![The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network - Annals of Oncology The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/59ddb1a7-296a-4bee-8e59-c6769708c4dc/gr1.jpg)
The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network - Annals of Oncology
![Bisphosphonates - RUSSELL - 2007 - Annals of the New York Academy of Sciences - Wiley Online Library Bisphosphonates - RUSSELL - 2007 - Annals of the New York Academy of Sciences - Wiley Online Library](https://nyaspubs.onlinelibrary.wiley.com/cms/asset/852c18be-ac2e-42f4-8b14-d24ab2ce1eaa/nyas_1117089_f9.gif)